Methods for treating diseases and conditions with inverse agonists

Details for Australian Patent Application No. 2004279438 (hide)

Owner Inverseon, Inc.

Inventors Bond, Richard A.

Agent Griffith Hack

Pub. Number AU-A-2004279438

PCT Pub. Number WO2005/034871

Priority 60/510,250 09.10.03 US; 60/555,797 23.03.04 US

Filing date 8 October 2004

Wipo publication date 21 April 2005

International Classifications

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

Event Publications

1 June 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 May 2006

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/034871 Priority application(s): WO2005/034871

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004279441-Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia

2004279437-Wheelchair designs and related enhancements